Clinical Trial Update: Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing docetaxel plus estramustine plus hydrocortisone versus docetaxel plus prednisone in advanced prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Estramustine (estramustine)
• HYDROCORTISONE (HYDROCORTISONE)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Neoplasms | Phase 3 | Status: TERMINATED